Medicaid Manufacturer Release: Authorized Generics Clarification

View in browser | Distributed by Center for Medicaid and CHIP Services (CMCS) Today the Centers for Medicare & Medicaid Services (CMS) published a manufacturer release (Release No. 112) related to Medicaid prescription drugs. The manufacturer release addresses manufacturer-specific situations related to the calculation of Average Manufacturer Price (AMP) for authorized generic and brand name drugs based upon the changes made by the Continuing Appropriations Act, 2020, and Health Extenders Act of 2019.  Medicaid Manufacturer Release No. 112

---

Stay connected with Medicaid.gov and CMS: